FIRST PREMIER BANK SAB Biotherapeutics, Inc. Transaction History

FIRST PREMIER BANK portfolio value:

$566,000
portfolio value

FIRST PREMIER BANK quarter portfolio value change:

-51.66%
quarter

SAB Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +23.77% 155.09K shares -380K $0.7 807.53K
Q2 2022 share Increase 0.00% 652.44K shares 946K $1.45 652.44K
Q1 2022 share Decrease -100.00% -832.55K shares -6.50M $3.76 0
Q4 2021 share Increase 0.00% 832.55K shares 6.50M $7.96 832.55K